PRNewsWire
30 Sept 2026, 00:12 UTC · 1h ago
Verdict
Headline leans bearish. We score QURE −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
uniQure's AMT-130 48-month data showed a 44% slowing of disease progression, down from the 75% slowdown reported at 36 months.
Newreleased September 29, 2026
So whatThe 31% drop in efficacy durability jeopardizes the BLA submitted on September 2, likely leading to an FDA Complete Response Letter.
More negative than 99% of claims this week
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
uniQure shares opened down 39% on September 29, 2026, following the release of the four-year data.
Newoccurred September 29, 2026
So whatThis wipeout of nearly 40% of market cap significantly increases the risk of dilutive equity financing to fund remaining operations.
More negative than 90% of claims this week
SueWallSt has launched an investigation into potential securities law violations regarding uniQure's AMT-130 clinical results and durability.
Newpress release dated Sep 29, 2026
So whatLegal contingencies and potential settlements would add unplanned liabilities to the balance sheet within the next 12-24 months.
More negative than 76% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company's stock plummeted 39% following disappointing clinical data for AMT-130 and is now facing a securities law investigation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
—
QURE hasn't traded since this ran. Last close $24.51 (Sep 29); the reaction starts at the next open.
QURE chart →
